Sign in

CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company

Verastem, Inc.

Sign in to watch
Ticker
VSTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
273269467
Phone
(781) 292-4200
Business address
117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
  1. 4 Open-market sale Director sold 600 shares at $2.80 ($1,680)
  2. 4 Open-market sale President and CEO sold 246 shares at $2.80 ($689)
  3. 4 Open-market sale President and CEO sold 3,245 shares at $2.16 ($7,009)
  4. 4 Open-market sale Chief Financial Officer sold 7 shares at $2.62 ($18)
  5. 4 Open-market sale Chief Financial Officer sold 28 shares at $3.15 ($88)
  6. 4 Grant or award Director acquired 8,333 shares (grant or award)
  7. 4 Grant or award Director acquired 8,333 shares (grant or award)
  8. 4 Grant or award Director acquired 8,333 shares (grant or award)
  9. 4 Grant or award Director acquired 8,333 shares (grant or award)
  10. 4 Open-market sale Chief Financial Officer sold 67 shares at $3.16 ($212)
  11. 4 Grant or award Director acquired 8,333 shares (grant or award)
  12. 4 Open-market sale Director sold 414 shares at an average $3.40 ($1,408)
  13. 4 Grant or award Director acquired 8,333 shares (grant or award)
  14. 4 Open-market sale President and CEO sold 427 shares at an average $3.37 ($1,439)
  15. 4 Open-market sale Director sold 928 shares at an average $3.39 ($3,145)
  16. 4 Grant or award Director acquired 8,333 shares (grant or award)
  17. 4 Open-market sale Chief Financial Officer sold 6 shares at $10.87 ($65)
  18. 4 Open-market sale Chief Financial Officer sold 25 shares at $12.02 ($301)
  19. 4 Open-market sale Chief Financial Officer sold 55 shares at $11.07 ($609)
  20. 4 Open-market sale Director sold 413 shares at an average $10.61 ($4,380)

Page 5 of 27 · 526 filings